Rescue of secretion of rare‐disease‐associated misfolded mutant glycoproteins in UGGT1 knock‐out mammalian cells
Traffic · 2024-01 · 25 (1)
DOI: 10.1111/tra.12927 ↗Kurz gefasst
Fachartikel in der Zeitschrift Traffic, online erschienen am 14.01.2024. Verfasst von Gabor Tax und 16 weiteren Autor:innen. Beteiligte Einrichtung: Leicester Institute of Chemical and Structural Biology and Department of Molecular and Cell Biology, University of Leicester, Leicester, England, UK. Hauptthemen laut MEDLINE: Rare Diseases, Protein Folding. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Swiss National Science Foundation, Wellcome Trust.
Abstract (Originalsprache)
Endoplasmic reticulum (ER) retention of misfolded glycoproteins is mediated by the ER‐localized eukaryotic glycoprotein secretion checkpoint, UDP‐glucose glycoprotein glucosyl‐transferase (UGGT). The enzyme recognizes a misfolded glycoprotein and flags it for ER retention by re‐glucosylating one of its N ‐linked glycans. In the background of a congenital mutation in a secreted glycoprotein gene, UGGT‐mediated ER retention can cause rare disease, even if the mutant glycoprotein retains activity (“responsive mutant”). Using confocal laser scanning microscopy, we investigated here the subcellular localization of the human Trop‐2‐Q118E, E227K and L186P mutants, which cause gelatinous drop‐like corneal dystrophy (GDLD). Compared with the wild‐type Trop‐2, which is correctly localized at the plasma membrane, these Trop‐2 mutants are retained in the ER. We studied fluorescent chimeras of the Trop‐2 Q118E, E227K and L186P mutants in mammalian cells harboring CRISPR/Cas9‐mediated inhibition of the UGGT1 and/or UGGT2 genes. The membrane localization of the Trop‐2 Q118E, E227K and L186P mutants was successfully rescued in UGGT1 −/− cells. UGGT1 also efficiently reglucosylated Trop‐2‐Q118E‐EYFP in cellula . The study supports the hypothesis that UGGT1 modulation would constitute a novel therapeutic strategy for the treatment of pathological conditions associated to misfolded membrane glycoproteins (whenever the mutation impairs but does not abrogate function), and it encourages the testing of modulators of ER glycoprotein folding quality control as broad‐spectrum rescue‐of‐secretion drugs in rare diseases caused by responsive secreted glycoprotein mutants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leicester Institute of Chemical and Structural Biology and Department of Molecular and Cell Biology, University of Leicester, Leicester, England, UK.
- Department of Biochemistry and Molecular Biology, and Program in Molecular and Cellular Biology, University of Massachusetts, Amherst, USA.
- Department of Medical, Oral and Biotechnological Sciences, "G. d'Annunzio" University of Chieti-Pescara, Pescara, Italy.
- Laboratory of Cancer Pathology, Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Pescara, Italy.
- Institute for Research in Biomedicine, Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Bellinzona, Switzerland.
- Institute of Glycobiology, Department of Biochemistry, University of Oxford, Oxford, UK.
ORCID-Profile: Gabor Tax, Ludovica Pantalone, Martina Ceci, Charlie J Hitchman, Johan C Hill, Andrea Lia, Carlos P Modenutti, Kees R Straatman, Angelo Santino, Maurizio Molinari, Nicole Zitzmann, Daniel N Hebert, Pietro Roversi, Marco Trerotola
Förderung
- NIGMS NIH HHS
- Swiss National Science Foundation
- Wellcome Trust
- NIH HHS
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- University of Leicester
- Biotechnology and Biological Sciences Research Council
- National Institutes of Health
Zitieren
APA
Tax, G., Guay, K. P., Pantalone, L., Ceci, M., Soldà, T., Hitchman, C. J., Hill, J. C., Vasiljević, S., Lia, A., Modenutti, C. P., Straatman, K. R., Santino, A., Molinari, M., Zitzmann, N., Hebert, D. N., Roversi, P., & Trerotola, M. (2024). Rescue of secretion of rare‐disease‐associated misfolded mutant glycoproteins in UGGT1 knock‐out mammalian cells. Traffic, 25(1). https://doi.org/10.1111/tra.12927
Vancouver
Tax G, Guay KP, Pantalone L, Ceci M, Soldà T, Hitchman CJ, et al. Rescue of secretion of rare‐disease‐associated misfolded mutant glycoproteins in UGGT1 knock‐out mammalian cells. Traffic. 2024;25(1). doi:10.1111/tra.12927
BibTeX
@article{Tax2024,
author = {Tax, Gabor and Guay, Kevin P and Pantalone, Ludovica and Ceci, Martina and Soldà, Tatiana and Hitchman, Charlie J and Hill, Johan C and Vasiljević, Snežana and Lia, Andrea and Modenutti, Carlos P and Straatman, Kees R and Santino, Angelo and Molinari, Maurizio and Zitzmann, Nicole and Hebert, Daniel N and Roversi, Pietro and Trerotola, Marco},
title = {Rescue of secretion of rare‐disease‐associated misfolded mutant glycoproteins in UGGT1 knock‐out mammalian cells},
journal = {Traffic},
year = {2024},
volume = {25},
number = {1},
doi = {10.1111/tra.12927}
}
EUVIMED